Seroquel is the brand name for quetiapine, an atypical antipsychotic medication used to treat several psychiatric conditions in adults. Originally developed for schizophrenia and bipolar disorder, Seroquel has become widely used in psychiatry at varying doses for conditions ranging from psychotic disorders to treatment-resistant depression and insomnia.
The FDA has approved quetiapine for schizophrenia, bipolar disorder (both manic and depressive episodes), and as an adjunct treatment for major depressive disorder in adults who have not responded adequately to antidepressants alone. It is available in immediate-release (IR) and extended-release (XR) formulations.
Quetiapine has a complex pharmacological profile, acting on multiple receptor systems in the brain. It blocks dopamine D2 receptors (which helps manage psychotic symptoms), serotonin 5-HT2A receptors (which contributes to mood stabilization), and histamine H1 receptors (which produces sedation). At lower doses, the antihistamine and serotonergic effects predominate, while higher doses engage more dopamine blockade.
This dose-dependent pharmacology is why psychiatrists prescribe Seroquel at vastly different doses for different conditions — 25 to 100 mg for insomnia, 300 mg for depression augmentation, and 400 to 800 mg for bipolar disorder or schizophrenia.
For bipolar disorder, Seroquel is effective during both manic episodes (reducing agitation, impulsivity, and psychotic features) and depressive episodes — one of the few medications approved for bipolar depression. It can be used as monotherapy or in combination with mood stabilizers like lamotrigine or lithium.
As an adjunct for treatment-resistant depression, Seroquel XR at 150 to 300 mg is added to an existing SSRI or SNRI when the antidepressant alone provides incomplete relief. This augmentation strategy has shown significant benefit in clinical trials and is a common approach in psychiatric practice.
At low doses, quetiapine is frequently prescribed off-label for insomnia, particularly in patients with co-occurring psychiatric conditions. However, using an antipsychotic solely for sleep in otherwise healthy adults is generally not recommended due to the metabolic side effects associated with long-term use.
Common side effects include drowsiness, dizziness, dry mouth, constipation, and weight gain. The sedation can be pronounced — especially during the first few days — and typically improves with continued use. Weight gain is a significant concern with quetiapine, with some adults gaining ten or more pounds over the first few months. Metabolic monitoring (weight, blood glucose, and lipid panels) is recommended at regular intervals.
Quetiapine can cause orthostatic hypotension (blood pressure drops when standing), which is most common during initial dose titration. More serious but less common risks include metabolic syndrome, tardive dyskinesia (involuntary movements with long-term use), elevated prolactin levels, and QT prolongation on electrocardiogram. Your psychiatrist will order baseline labs and monitor these parameters throughout treatment.
Managing complex conditions like bipolar disorder, treatment-resistant depression, and psychotic disorders requires experienced psychiatric care. At Elevate Psychiatry, our board-certified psychiatrists provide comprehensive evaluations and individualized medication management for adults in Miami and throughout Florida via telehealth.
Schedule an appointment to discuss your treatment options.
This content is for informational purposes only and does not replace professional medical advice, diagnosis, or treatment. Always consult a qualified psychiatrist before starting, changing, or stopping any medication.
